Smallpox vaccine adverse events among civilians--United States, March 4-10, 2003.
During the civilian smallpox vaccination program, CDC, the Food and Drug Administration, and state health departments are conducting surveillance for vaccine-associated adverse events. In the first stage of the program, active surveillance is being conducted for potentially life-threatening, moderate-to-severe, and other serious adverse events and for vaccinia transmission to contacts of vaccinees (Table). Nonserious events are reported through passive surveillance and are expected to be underreported. This report summarizes smallpox vaccine adverse events reported among civilians vaccinated as of March 7, 2003, and among contacts of vaccinees, received by CDC from the Vaccine Adverse Event Reporting System (VAERS) as of March 10.
D000328:Adult; D016907:Adverse Drug Reaction Reporting Systems; D005260:Female; D006282:Health Personnel; D006801:Humans; D008297:Male; D008875:Middle Aged; D008889:Military Personnel; D011159:Population Surveillance; D012900:Smallpox Vaccine / Q000009:adverse effects*; D014481:United States; D014611:Vaccination / Q000009:adverse effects
D012900:Smallpox Vaccine